Filing Details
- Accession Number:
- 0001161697-22-000425
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-30 17:00:22
- Reporting Period:
- 2022-08-26
- Accepted Time:
- 2022-08-30 17:00:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402652 | Alicia Grande | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Vp, Treasurer And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-26 | 11,095 | $14.40 | 464,442 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-29 | 20,000 | $14.14 | 444,442 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-29 | 20,000 | $14.20 | 424,442 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-29 | 17,000 | $14.28 | 407,442 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.